Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Journal of Viral Hepatitis|January 15, 2016
The expanding toolbox for hepatitis C virus researchA M Ortega-Prieto, M DornerNature Communications|February 16, 2018
3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infectionA M Ortega-Prieto, J K Skelton, S N Wai, et al.Scientific Reports|January 14, 2018
T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other FlavivirusesC J Reynolds, O M Suleyman, A M Ortega-Prieto, et al.Current Medical Research and Opinion|January 1, 1984
Effect of middle-term gliclazide treatment on insulin secretion in non-insulin dependent diabeticsJ M Brogard, M Pinget, M DornerMMW, Munchener Medizinische Wochenschrift|May 13, 1977
[Essential labile diabetes (author's transl)]M Dorner, M Pinget, J M BrogardChemotherapy|January 1, 1976
Adjustment of cephaloridine (Keflodin): dosage according to its pharmacokineticsJ M Brogard, C Brandt, M Dorner, et al.Annales De Medecine Interne|January 1, 1984
[Evaluation of the biliary passage of beta-lactam antibiotics]J M Brogard, B Audhuy, M Pinget, et al.Diabete & Metabolisme|May 1, 1984
[Prolonged treatment of sugar diabetes by subcutaneous insulin infusion using a peristaltic pump and an insulin solution concentrated to 100 Iu/ml]M Pinget, R Wirion, J F Blickle, et al.Environmental Science & Technology|July 21, 2004
Estimating potential environmental loadings of Cryptosporidium spp. and Campylobacter spp. from livestock in the Grand River Watershed, Ontario, CanadaSarah M Dorner, Peter M Huck, Robin M SlawsonJournal of Clinical Pharmacology|October 1, 1975
Determination of cefalexin pharmacokinetics and dosage adjustments in relation to renal functionJ M Brogard, M Pinget, M Dorner, et al.Pageof 7